4503Astellas Pharma4503 info
$9.63info-1.08%24h
Global rank949
Market cap$17.31B
Change 7d-3.93%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Astellas Pharma (4503) Stock Overview

    Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. The company was founded in 1923 and is headquartered in Tokyo, Japan.

    4503 Stock Information

    Symbol
    4503
    Address
    2-5-1, Nihonbashi-HonchoTokyo, 103-8411Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.astellas.com
    Country
    🇯🇵 Japan
    Phone Number
    81 3 3244 3000

    Astellas Pharma (4503) Price Chart

    -
    Value:-

    Astellas Pharma Overview: Key Details and Summary

    Stock data
    2025
    Change
    Price
    $9.63
    N/A
    Market Cap
    $17.31B
    N/A
    Shares Outstanding
    1.80B
    N/A
    Employees
    14.48K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2025 Topstocks.org